Clinical Flashcards
Upper GI bleeding (UGIB) management?
- Upper = up the ligament of Treizt
- Major diagnosis: gastric or duodenal ulcer, gastric or oesophageal varices (due to portal hypertension from liver cirrhosis, high mortality rate), erosive esophagitis
- After history and vital signs, we have to do lab tests (CBC, chemistry, liver and coagulation studies)
- In upper GI bleeding, the blood urea nitrogen level typically increases to a greater extent than the creatinine level
- Patients should undergo endoscopic evaluation within 12-24 hours
Lower GI bleeding (LGIB) management?
- About 15 to 20% of patients who present with hematochezia (passage of red blood or clots per rectum), have an upper GI source of brisk bleeding
- Same evaluation as UGIB
- Most patients then need endoscopic evaluation
- Flexible sigmoidoscopy/anoscopy, especially if anorectal/distal colon bleeding
- Colonoscopy allows for diagnosis and possible hemostasis of amenable lesions
- Red blood cell scan if major bleeding and the source cannot be identified by colonoscopy
- Major causes: diverticulosis, internal hemorrhoids, ischemic colitis, ulcers
UGIB treatments?
- ABCs (IV, intubation, INR correction)
- Type and Cross-Match
- Fluid resuscitation
- Crystalloid
- Blood
- Risk stratification
- Clinical
- Endoscopic
- Available treatments:
- Injection
- Thermal coagulation,
- Mechanical compression (clips)
- Hemostatic powders
- Endoscopic therapy is reserved for lesions that have high-risk stigmata: we use proton pump inhibitors to suppress acid secretion and promote platelet aggregation
- Alternative management for refractory bleeding: radiological percutaneous procedures, surgery and radiotherapy
- Variceal UGIB treatment: pharmacotherapy + endoscopy + radiological therapy + temporarily balloon temponade/stenting
LGIB treatments?
- Colonoscopy
- Alternative therapies: angiographic embolization, surgery
- Prognostic dependant on the source of bleeding
Obscure (middle) GIB?
- Videocapsule endoscopy; enteroscopy
- Most common in small intestine (not accessible by colonoscopy and endoscopy)
- Vascular lesions are the most common cause, followed by iron deficiency
Dental carries Pathological factors?
- acid producing bacteria
- fermentable carbohydrates
- insufficient saliva (xerostomia)
Dental carries Protective factors?
- Fluoride
- Saliva flow
Main risk factor for dental carries?
- Poverty (social determinants of health)
- Lifestyle and behavioural
Caries disease process signs?
- Color: white, brown or back color
- Location: where biofilm can stagnate (root)
- Shape
- Tooth surface integrity
Stages of dental carries?
D1 – Subclinical initial lesion
D2 – Enamel non-cavitated lesions
D3 – Enamel cavitated lesions
D4 – Pulp lesions
Important prevention guidelines?
- Children should not fall asleep with milk or juice
- We should be aware of the sugar contained in the medication we prescribe
- Brush the teeth and oral hygiene EARLY
Clinical manifestation of pancreas disease?
Pancreatitis
- Sudden onset abdomen pain radiating to the back
- May be relieved by leaning forward
- +/- jaundice
- Ecchymotic discoloration
Neoplastic (depends on location)
- Head of the pancreas will likely block the ducts and the patient will present with symptoms earlier (jaundice, light stools, dark urine)
- Body or tail usually present later when there is spreading to other organs (pain, weight loss).
Approach to liver problem?
1. History taking
Place of birth, family history, blood transfusion prior to 1990, alcohol, IV or nasal drugs, tattoos or piercing, vaccination/medical/dental care in other country, barber shops (razors), prison or military service, sex, metabolic syndrome
2. Liver function tests (LFTs)
Are NOT AST, ALT, ALP or GGT: these are karmers of liver injury NOT dysfunction
Function tests:
- PT, albumin, conjugated biliburin
- Glucose control, lipids
- Galactose elimination, caffeine clearance or aminopyrine breath test
The best liver function test: INR (vitamin K dependent clothing factor)
3. Ultrasound to determine if problem is intrahepatic or extrahepatic, blood flow, screen cancer
4. Fibroscan: stiffness of the liver, replaces biopsy
5. CT or MRI scans
6. Check for thyroid and celiac disease
Liver disease and decompensation?
- Hepatitis B and C
HBSAG: hepatitis B surface is the most important serology test
Core anti-body: tells if you had a natural , not a vaccine
- NASH
- ETOH
Healthy –> fatty –> fibrosis –> cirrhosis
- Drug induced liver injury
- Autoimmune liver disease
Causes of cirrhosis?
- Primary liver disorders: obesity
- Bile ductal blockage
- Drugs and toxins: alcohol
- Infections: hepatitis B and C
Key pathologic feature of cirrhosis?
FIBROSIS
The key step in the pathophysiology of liver fibrogenesis is the balance between ECM deposition and removal. Histologically: kupffer cells reduced, endothelial cell, hepacotytes damage, lymphocytes and neutrophils ® created autocrine inflammation stimuli
LIVER FIBROSIS: THE SINGLE MOST IMPORTANT PREDICTOR OF MORTALITY
Cirrhosis diagnosis?
- Clinical features: obesity, hypertension, insulin resistance, fx, hepatomegaly…
- Biopsy: inflammation, FIBROSIS, cellular infiltration
- Imaging: IS, MRI, CT, transient Elastography (FibroScan)
- Biomarkers: APRI=[AST (/ULN) x 100] / Platelet (109/L) (value >2 means presence of cirrhosis), ALT, AST, biliburin, proinflammatory, cytokines…
Complications of cirrhosis?
- Palmar erythema
- Hypogonadism
- Gynecomastia
- Splenomegaly
- Spider nevi, caput medusa (falciform ligament)
- Ascites, edema: PH, hypoalbuminemia, 2nd hyperaldosteronism, arterial vasodilatation
- Varices and hemorrhoids
- Encephalopathy
- Itching
- Increased susceptibility to drug toxicity
- Liver cancer
Treatment of cirrhosis?
- Screening for HCC
- Screening for endoscopic signs of portal hypertension
- Transplantation MELD score > 15 (based on serum bilirubin and creatinine)
- Treatment of complications: HE, ascites,
Risk factors of IBD?
- Age – more likely among younger patients3
- Ethnicity – more likely among Caucasians, in particular Ashkenazi Jews3
- Family history – 15-25% risk of IBD if 1st degree relative affected. 60% concordance in monozygotic twins
- Geography – more common in US and Europe4,5
- Smoking – Active smokers are more than 2 times as likely to develop CD than nonsmokers, but less likely to develop UC3
Comparison UC and CD
Extraintestinal Manifestations of IBD?
- C = Cholangitis (primary sclerosing cholangitis)
- H = Hematologic (anemia, hemolysis, amyloid)
- E = Eye (episcleritis, uveitis)
- A = Arthritis (peripheral, axial)
- T = Thromboembolism
- S = Skin (e. nodosum, pyoderma gangrenosum)
What is celiac disease?
- T cell mediated immune disease of the small intestine triggered by gliadin (gluten protein) found in wheat, barley and rye
- Genetic factors (chromosome 6)
- HLA DQ2 and DQ8 gene loci
- > 98% in celiac disease but present in 30% of Caucasion’s: necessary but not sufficient
Diagnosis of celiac disease?
IgA EMA (endomysial antibodies)
–Gold standard.
–If treated, the test becomes negative.
IgA tTG (tissue transglutaminase)
–Cheaper and more available
–False-positive in patients with other auto-immune or liver diseases
–Decreases when on a gluten-free diet
–can be used to assess compliance (should fall to normal or “baseline” within 3-6 months)
–False negatives in IgA deficient patients (IgG TTG)
Clinical manifestations of celiac disease?
- Mean age at presentation 45
- Episodic diarrhea (up to 10x per day): nocturnal or early morning diarrhea is common
- Distention
- Steatorrhea
- Flatulence
- Weight loss
- Vague abdominal discomfort/fatigue
- Anemia: ion, folate, B12
- Recurrent aphthous ulcers
- Systemic manifestations: kidney disease, dermatitis herpetiformis, neuropsychoatric disease, metabolic bone disease
- Complications: malignancy
Types of celiac disease?
- Classic or typical celiac disease: gluten-sensitive enteropathy found in association with villous atrophy, malabsorption (steatorrhea, wt loss, vit def) and resolution of symptoms and mucosal lesions on a gluten free diet
- Atypical celiac sprue: gluten-sensitive enteropathy with only minor GI symptoms, but atypical manifestations including anemia, osteoporosis, arthritis, neurological symptoms and infertility
- Asymptomatic (silent) celiac disease: gluten-sensitive enteropathy found after serologic screening in asymptomatic patients
- Latent (potential) celiac disease: Patients who have normal villous architecture on a gluten-containing diet (but have serological markers positive for celiac disease)
- Refractory celiac disease: Symptomatic, severe small intestinal villous atrophy but does not respond to at least 6 months of a strict gluten-free diet